Amid opioid concerns, FDA approves Peninsula company's powerful painkiller

AcelRx Pharmaceuticals Inc. won its first Food and Drug Administration approval Friday of a restricted-use opioid delivery system, but the nation's top drug regulator issued an atypical statement to assuage concerns about another highly addictive painkiller hitting the market. Redwood City-based AcelRx's (NASDAQ: ACRX) Dsuvia is a single tablet of the opioid sufentanil, pre-packaged inside a three-inch plastic applicator that lets medical staff deliver the drug under the tongue. It faced a tough…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news